{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:06:45Z","timestamp":1773882405490,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009411","name":"Universite Paris-Est Creteil Val de Marne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.modpat.2025.100875","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:23:59Z","timestamp":1756250639000},"page":"100875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus\u2013Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7816-1900","authenticated-orcid":false,"given":"Barbara","family":"Burroni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Lamaison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Poullot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu","family":"Pirlog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrielle","family":"Robe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Bossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena-liana","family":"Veresezan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouhoum","family":"Sako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Labouyrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caoimhe","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-905X","authenticated-orcid":false,"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.modpat.2025.100875_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2025.100875_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.modpat.2025.100875_bib3","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100875_bib4","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.modpat.2025.100875_bib5","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100875_bib6","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100875_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100875_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.2020010387","article-title":"Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project","volume":"138","author":"Advani","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2025.100875_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100875_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified","volume":"19","author":"Grogg","year":"2006","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100875_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3324\/haematol.2009.010991","article-title":"The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation","volume":"95","author":"Marafioti","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.modpat.2025.100875_bib14","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.2023021786","article-title":"A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas","volume":"144","author":"de Leval","year":"2024","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2025.100875_bib15","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.modpat.2025.100875_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.modpat.2025.100875_bib21","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2025.100875_bib22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.modpat.2025.100875_bib23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"52","key":"10.1016\/j.modpat.2025.100875_bib24","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1073\/pnas.1617929114","article-title":"The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development","volume":"113","author":"Lemonnier","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.modpat.2025.100875_bib25","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100875_bib26","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/cancers13061414","article-title":"EBV and the pathogenesis of NK\/T cell lymphoma","volume":"13","author":"Montes-Mojarro","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100875_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00428-023-03616-4","article-title":"Cytotoxic peripheral T-cell lymphomas and EBV-positive T\/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Climent","year":"2023","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/j.modpat.2025.100875_bib29","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","volume":"107","author":"Wai","year":"2022","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.modpat.2025.100875_bib30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","article-title":"Updated guidelines for chronic active Epstein-Barr virus disease","volume":"118","author":"Kawada","year":"2023","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2141.2007.06620.x","article-title":"Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load","volume":"138","author":"Zhou","year":"2007","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100875_bib33","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2025.100875_bib34","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.V80.7.1804.1804","article-title":"Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type","volume":"80","author":"Anagnostopoulos","year":"1992","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.modpat.2025.100875_bib35","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/his.14919","article-title":"A nodal EBV-positive T cell lymphoma with a T follicular helper cell phenotype","volume":"83","author":"Zhang","year":"2023","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.modpat.2025.100875_bib37","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/bloodadvances.2023012019","article-title":"EBV+ nodal T\/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome","volume":"8","author":"Kato","year":"2024","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.modpat.2025.100875_bib38","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines","volume":"89","author":"Coleman","year":"2015","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.modpat.2025.100875_bib39","doi-asserted-by":"crossref","first-page":"e00813","DOI":"10.1128\/JVI.00813-18","article-title":"Epstein-Barr virus type 2 infects T cells and induces B cell lymphomagenesis in humanized mice","volume":"92","author":"Coleman","year":"2018","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100875_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jix363","article-title":"Epstein-Barr virus type 2 infects T cells in healthy Kenyan children","volume":"216","author":"Coleman","year":"2017","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.modpat.2025.100875_bib41","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3390\/cancers14122899","article-title":"Epstein-Barr virus (EBV) is mostly latent and clonal in angioimmunoblastic T cell lymphoma (AITL)","volume":"14","author":"Bahri","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.modpat.2025.100875_bib42","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100875_bib43","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/jvi.64.9.4084-4092.1990","article-title":"Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes","volume":"64","author":"Sample","year":"1990","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<185::AID-PATH997>3.0.CO;2-9","article-title":"Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides","volume":"184","author":"Delfau-Larue","year":"1998","journal-title":"J Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100875_bib45","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.modpat.2025.100875_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","article-title":"Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall","volume":"44","author":"Egan","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1182\/bloodadvances.2020003081","article-title":"Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma","volume":"5","author":"Lemonnier","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.modpat.2025.100875_bib48","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PAS.0000000000001984","article-title":"Overlapping features of primary cutaneous marginal zone lymphoproliferative disorder and primary cutaneous CD4 + small\/medium T-cell lymphoproliferative disorder : a diagnostic challenge examined by genomic analysis","volume":"47","author":"Obiorah","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100875_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.4920","article-title":"Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells","volume":"242","author":"Lemonnier","year":"2017","journal-title":"J Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100875_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41389-020-00259-x","article-title":"New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP","volume":"9","author":"Mhaidly","year":"2020","journal-title":"Oncogenesis"},{"issue":"9","key":"10.1016\/j.modpat.2025.100875_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2017-11-818617","article-title":"RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice","volume":"132","author":"Ng","year":"2018","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.modpat.2025.100875_bib52","doi-asserted-by":"crossref","first-page":"10641","DOI":"10.1073\/pnas.162360499","article-title":"The crystal structure of human CD21: implications for Epstein\u2013Barr virus and C3d binding","volume":"99","author":"Prota","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.modpat.2025.100875_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00428-20","article-title":"CD21 (complement receptor 2) is the receptor for Epstein-Barr virus entry into T cells","volume":"94","author":"Smith","year":"2020","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.151.1.92","article-title":"Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation","volume":"151","author":"Panzer-Gr\u00fcmayer","year":"1993","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100875_bib55","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/intimm\/11.11.1841","article-title":"Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes","volume":"11","author":"Fischer","year":"1999","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100875_bib56","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.170.12.5993","article-title":"Acquisition of viral receptor by NK cells through immunological synapse","volume":"170","author":"Tabiasco","year":"2003","journal-title":"J Immunol"},{"issue":"48","key":"10.1016\/j.modpat.2025.100875_bib57","doi-asserted-by":"crossref","first-page":"20738","DOI":"10.1073\/pnas.1009635107","article-title":"Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission","volume":"107","author":"Van Prooyen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.modpat.2025.100875_bib58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal Centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100875_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.modpat.2025.100875_bib60","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","article-title":"Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms","volume":"4","author":"Lewis","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.modpat.2025.100875_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.4898","article-title":"TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma","volume":"242","author":"Schwartz","year":"2017","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100875_bib62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5376","article-title":"Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell","volume":"250","author":"Yao","year":"2020","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100875_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01987-16","article-title":"Restricted TET2 expression in germinal center type B cells promotes stringent Epstein-Barr virus latency","volume":"91","author":"Wille","year":"2017","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100875_bib64","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s12026-024-09531-3","article-title":"EBV + B cell-derived exosomes promote EBV-associated T\/NK-cell lymphoproliferative disease immune evasion by STAT3\/IL-10\/PD-L1 pathway","volume":"72","author":"Chen","year":"2024","journal-title":"Immunol Res"},{"key":"10.1016\/j.modpat.2025.100875_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.02.009","article-title":"Wild-type IDH2 contributes to Epstein\u2013Barr virus-dependent metabolic alterations and tumorigenesis","volume":"36","author":"Shi","year":"2020","journal-title":"Mol Metab"},{"issue":"13","key":"10.1016\/j.modpat.2025.100875_bib66","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","article-title":"Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study","volume":"108","author":"Dupuis","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2025.100875_bib67","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/cancers13040610","article-title":"Comprehensive Epstein-Barr virus transcriptome by RNA-sequencing in angioimmunoblastic T cell lymphoma (AITL) and other lymphomas","volume":"13","author":"Bayda","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.modpat.2025.100875_bib68","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A\u221702 is associated with a reduced risk and HLA-A\u221701 with an increased risk of developing EBV+ Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:25:24Z","timestamp":1772853924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0893395225001735"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100875","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus\u2013Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100875"}}